These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15177778)

  • 1. Bio-markers of disease activity and response to therapy in multiple sclerosis.
    Miller A; Glass-Marmor L; Abraham M; Grossman I; Shapiro S; Galboiz Y
    Clin Neurol Neurosurg; 2004 Jun; 106(3):249-54. PubMed ID: 15177778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple sclerosis physiopathology].
    Créange A
    Soins; 2009 Nov; (740):32-5. PubMed ID: 20014530
    [No Abstract]   [Full Text] [Related]  

  • 3. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
    J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers of the inflammatory phase of multiple sclerosis.
    Uccelli A; Pedemonte E; Narciso E; Mancardi G
    Neurol Sci; 2003 Dec; 24 Suppl 5():S271-4. PubMed ID: 14652787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
    Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
    J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG.
    Hestvik AL; Vartdal F; Fredriksen AB; Thompson KM; Kvale EO; Skorstad G; Bogen B; Holmoy T
    Scand J Immunol; 2007 Oct; 66(4):393-401. PubMed ID: 17850583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
    Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphokines and monokines].
    Lohmann-Matthes ML
    Beitr Infusionther Klin Ernahr; 1987; 18():244-53. PubMed ID: 3125828
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood test may predict MS progression.
    Health News; 2003 Sep; 9(9):5-6. PubMed ID: 14584469
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
    Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinodaphnine induces apoptosis through increased nitric oxide, reactive oxygen species and down-regulation of NF-kappaB signaling in human hepatoma Mahlavu cells.
    Hsieh TJ; Liu TZ; Lu FJ; Hsieh PY; Chen CH
    Food Chem Toxicol; 2006 Mar; 44(3):344-54. PubMed ID: 16168547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells.
    Cavaletti G; Perseghin P; Dassi M; Oggioni N; Sala F; Braga M; Lolli F; Riccio P; Carlone G; Zoia C; Tagliabue E; Stanzani L; Galbiati S; Rigamonti L; Marmiroli P; Ferrarese C; Frattola L; Tredici G
    J Biol Regul Homeost Agents; 2004; 18(1):9-17. PubMed ID: 15323355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F; Chojnacki A; Weiss S; Antel JP
    Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
    [No Abstract]   [Full Text] [Related]  

  • 20. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.